STEPHANIE KLAIR: Open Payments
NPI 1750797635 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 12 payments from 8 companies in 2025. Trend: 2023 $150 · 2024 $257 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $89 |
| Kestra Medical Technology Services, Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Amgen Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: VYNDAQEL, Assure WCD, LEQVIO, CLEVIPREX, WAINUA, AVEIR, LifeVest.
Industry payments across DE — which companies pay providers there.
